Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol and Hydroxychloroquine with Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
NCT04524702Phase 2Completed
- Sponsor
- Emory University
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol, hydroxychloroquine in pancreatic adenocarcinoma (PDAC), sponsored by Emory University. Started Sep 2020; status: completed.
02
Drugs
paricalcitolhydroxychloroquine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04524702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04524702.